<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37211198</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1740</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><PubDate><Year>2024</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Progress in cardiovascular diseases</Title><ISOAbbreviation>Prog Cardiovasc Dis</ISOAbbreviation></Journal><ArticleTitle>Cardiopulmonary testing in long COVID-19 versus non-COVID-19 patients with undifferentiated Dyspnea on exertion.</ArticleTitle><Pagination><StartPage>71</StartPage><EndPage>76</EndPage><MedlinePgn>71-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pcad.2023.05.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0033-0620(23)00053-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dyspnea and fatigue are characteristics of long SARS-CoV-2 (COVID)-19. Cardiopulmonary exercise testing (CPET) can be used to better evaluate such patients.</AbstractText><AbstractText Label="RESEARCH QUESTION" NlmCategory="OBJECTIVE">How significantly and by what mechanisms is exercise capacity impaired in patients with long COVID who are coming to a specialized clinic for evaluation?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">We performed a cohort study using the Mayo Clinic exercise testing database. Subjects included consecutive long COVID patients without prior history of heart or lung disease sent from the Post-COVID Care Clinic for CPET. They were compared to a historical group of non-COVID patients with undifferentiated dyspnea also without known cardiac or pulmonary disease. Statistical comparisons were performed by t-test or Pearson's chi<sup>2</sup> test controlling for age, sex, and beta blocker use where appropriate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found 77 patients with long COVID and 766 control patients. Long COVID patients were younger (47&#xa0;&#xb1;&#xa0;15 vs 50&#xa0;&#xb1;&#xa0;10&#xa0;years, P&#xa0;&lt;&#xa0;.01) and more likely female (70% vs 58%, P&#xa0;&lt;&#xa0;.01). The most prominent difference on CPETs was lower percent predicted peak V&#x307;O<sub>2</sub> (73&#xa0;&#xb1;&#xa0;18 vs 85&#xa0;&#xb1;&#xa0;23%, p&#xa0;&lt;&#xa0;.0001). Autonomic abnormalities (resting tachycardia, CNS changes, low systolic blood pressure) were seen during CPET more commonly in long COVID patients (34 vs 23%, P&#xa0;&lt;&#xa0;.04), while mild pulmonary abnormalities (mild desaturation, limited breathing reserve, elevated V&#x307;<sub>E</sub>/V&#x307;CO<sub>2</sub>) during CPET were similar (19% in both groups) with only 1 long COVID patient showing severe impairment.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">We identified severe exercise limitation among long COVID patients. Young women may be at higher risk for these complications. Though mild pulmonary and autonomic impairment were common in long COVID patients, marked limitations were uncommon. We hope our observations help to untangle the physiologic abnormalities responsible for the symptomatology of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Alejandra Meza</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Darrell B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelloni</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niven</LastName><ForeName>Alexander S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Ravindra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squires</LastName><ForeName>Ray W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonikowske</LastName><ForeName>Amanda R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allison</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America; Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: allison.thomas@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prog Cardiovasc Dis</MedlineTA><NlmUniqueID>0376442</NlmUniqueID><ISSNLinking>0033-0620</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="Y">Dyspnea</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="Y">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="Y">Exercise Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005082" MajorTopicYN="N">Physical Exertion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary exercise testing</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">autonomic abnormalities</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>21</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37211198</ArticleId><ArticleId IdType="pmc">PMC10198738</ArticleId><ArticleId IdType="doi">10.1016/j.pcad.2023.05.005</ArticleId><ArticleId IdType="pii">S0033-0620(23)00053-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stokes E.K., Zambrano L.D., Anderson K.N., et al. Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302472</ArticleId><ArticleId IdType="pubmed">32555134</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham M., Sudre C., May A., et al. Changes in symptomatology, reinfection and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health. 2021;6:e335&#x2013;e345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041365</ArticleId><ArticleId IdType="pubmed">33857453</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  December. 2021. COVID-19: About the variants.https://www.cdc.gov/coronavirus/2019-ncov/variants/about-variants.html Accessed January 31, 2022.</Citation></Reference><Reference><Citation>NBC News . December. 2021. Omicron symptoms: what we know about illness caused by the new variant.https://www.nbcnews.com/health/health-news/omicron-symptoms-covid-what-to-know-rcna9469 Accessed January 31, 2022.</Citation></Reference><Reference><Citation>Healthline Omicron symptoms: How they Compare With Other Coronavirus Variants. 2021. https://www.healthline.com/health-news/omicron-symptoms-how-they-compare-with-other-coronavirus-variants Accessed January 31, 2022.</Citation></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., et al. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9(12):927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz Y., Van Herck M., Delbressine J., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R., Grach S., Ghosh A., et al. The female predominant persistent immune dysregulation of the post COVID syndrome: A cohort study. Mayo Clin Proc. 2021;96</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta D., Normandin E., ZuWallack R. Cardiopulmonary exercise testing in the assessment of exertional dyspnea. Ann Thorac Med. 2015;10(2):77&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375746</ArticleId><ArticleId IdType="pubmed">25829957</ArticleId></ArticleIdList></Reference><Reference><Citation>Guazzi M., Arena R., Halle M., et al. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2016;133:e694&#x2013;e711.</Citation><ArticleIdList><ArticleId IdType="pubmed">27143685</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani R., Lavie C., Mehra M. Cardiopulmonary exercise testing: how do we differentiate the cause of Dyspnea? Circulation. 2004;110:e27&#x2013;e31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15277333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A., Dannerbeck L., Lange T.J., et al. Cardiopulmonary exercise pattern in patients with persistent dyspnea after recovery from COVID-19. Multidiscip Respir Med. 2021;16:732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Chen R., Geng Q., et al. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J. 2021 Jan 28;57(1):2004265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758779</ArticleId><ArticleId IdType="pubmed">33361097</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P., De Marzo V., Lotti R., et al. Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up. MedRxiv. 2020 doi: 10.1101/2020.11.15.20231985. preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.15.20231985</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2022;161(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shang Y., Song W., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Daida H., Allison T.G., Johnson B.D., Squires R.W., Gau G.T. Comparison of peak exercise oxygen uptake in men versus women in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997 Jul 1;80(1):85&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">9205028</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2) 92&#x2013;98.35.</Citation><ArticleIdList><ArticleId IdType="pubmed">5523831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminsky L.A., Arena R., Myers J., et al. Updated reference standards for cardiorespiratory fitness measured with cardiopulmonary exercise testing: data from the fitness registry and the Importance of Exercise National Database (FRIEND) Mayo Clin Proc. 2022 Feb;97(2):285&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">34809986</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalski J., Allison T., Miller T. The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases. Circulation. 2012;126:2465&#x2013;2472.</Citation><ArticleIdList><ArticleId IdType="pubmed">23091065</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminsky L.A., Harber M.P., Imboden M.T., Arena R., Myers J. Peak ventilation reference standards from exercise testing: from the FRIEND registry. Med Sci Sports Exerc. 2018 Dec;50(12):2603&#x2013;2608.</Citation><ArticleIdList><ArticleId IdType="pubmed">30095740</ArticleId></ArticleIdList></Reference><Reference><Citation>Howley E.T., Bassett D.R., Jr., Welch H.G. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc. 1995;27:1292&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pubmed">8531628</ArticleId></ArticleIdList></Reference><Reference><Citation>Issekutz B., Birkhead N.C., Rodahl K. The use of respiratory quotients in assessment of aerobic work capacity. J Appl Physiol. 1962;17:47&#x2013;50.</Citation></Reference><Reference><Citation>Edvardsen E., Hem E., Anderssen S.A. End criteria for reaching maximal oxygen uptake must be strict and adjusted to sex and age: a cross-sectional study. PLoS One. 2014 Jan 14;9(1):e85276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891752</ArticleId><ArticleId IdType="pubmed">24454832</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaf Y., Barout A., Alhamid A., et al. Peak systolic blood pressure during the exercise test: reference values by sex and age and association with mortality. Hypertension. 2021 Jun;77(6):1906&#x2013;1914.</Citation><ArticleIdList><ArticleId IdType="pubmed">33866799</ArticleId></ArticleIdList></Reference><Reference><Citation>Syd&#xf3; N., Abdelmoneim S.S., Mulvagh S.L., Merkely B., Gulati M., Allison T.G. Relationship between exercise heart rate and age in men vs women. Mayo Clin Proc. 2014 Dec;89(12):1664&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pubmed">25441400</ArticleId></ArticleIdList></Reference><Reference><Citation>Brubaker P.H., Kitzman D.W. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011 Mar 8;123(9):1010&#x2013;1020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065291</ArticleId><ArticleId IdType="pubmed">21382903</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X.G., Hansen J.E., Garatachea N., Storer T.W., Wasserman K. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med. 2002 Dec 1;166(11):1443&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pubmed">12450934</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. E Clinical Medicine. 2021 Jan 7;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P., De Marzo V., Lotti R., et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol. 2021;340:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302817</ArticleId><ArticleId IdType="pubmed">34311011</ArticleId></ArticleIdList></Reference><Reference><Citation>Skj&#xf8;rten I., Ankerstjerne O.A.W., Trebinjac D., et al. Cardiopulmonary exercise capacity and limitations 3&#xa0;months after COVID-19 hospitalisation. Eur Respir J. 2021;58(2):2100996. Published 2021 Aug 26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonbank K., Lehmann A., Bernitzky D., et al. Predictors of prolonged cardiopulmonary exercise impairment after COVID-19 infection: A prospective observational study. Front Med. 2021;8:773788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8740119</ArticleId><ArticleId IdType="pubmed">35004742</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Sun K., Tahir P., et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: A systematic review and meta analysis. JAMA Netw Open. 2022;5(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleszak F., Maryniak A., Botti E., et al. Myocarditis Associated With COVID-19. Am J Med Case Rep. 2020;8(12):498&#x2013;502.</Citation></Reference><Reference><Citation>Luchian M., Motoc A., Lochy S., et al. Subclinical myocardial dysfunction in patients with persistent Dyspnea one year after COVID-19. Diagnostics. 2022;12(57)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775030</ArticleId><ArticleId IdType="pubmed">35054224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul C., Grimsmo J., Mecinaj A., et al. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc. 2022;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238505</ArticleId><ArticleId IdType="pubmed">35048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist J., Chen M., Collier G., et al. Hyperpolarized 129Xe MRI abnormalities in DYSPNEIC patient 3 months after COVID-19 Pneumonia: preliminary results. Radiology. 2021;301:e353&#x2013;e360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W., et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;16:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G., Ricci F., Recce V., et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: What do we know? J Cardiovasc Dev Dis. 2021;8(156)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., et al. Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies. Clin Med (Lond) 2021 Jan;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F.J. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28(1):67&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28730326</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranyo J., Bazan V., Llados G., et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. 2022;12:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J., Amato A.A. Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol. 2021;34(5):669&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452251</ArticleId><ArticleId IdType="pubmed">34155186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross R., Blair S.N., Arena R., et al. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association. Circulation. 2016 Dec 13;134(24):e653&#x2013;e699.</Citation><ArticleIdList><ArticleId IdType="pubmed">27881567</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>